赛隆药业董事会全体辞职，董事长蔡南桂留任其他职务

Group 1 - The chairman and several executives of *ST Sailong have collectively resigned due to a change in the company's control, with all nine members of the fourth board submitting resignation letters [1] - Cai Nanguai, the chairman and president, will continue to hold other positions within the company after resigning from his roles, and he holds 67.51 million shares, representing a 47.23% stake in a major shareholder [1] - The board expressed sincere gratitude for Cai Nanguai's significant contributions to the company's strategic decision-making, compliance governance, and stable operations during his tenure [1] Group 2 - On July 15, *ST Sailong announced a forecast for the first half of the year, expecting a net loss attributable to shareholders of between 13 million to 18 million yuan, compared to a profit of 1.7647 million yuan in the same period last year [2]